**Background**: High-dose, adjuvanted, and recombinant influenza vaccines may offer improved effectiveness among older adults compared to standard-dose, unadjuvanted, inactivated vaccines. However, the Advisory Committee on Immunization Practices …
Work presented to the Advisory Committee on Immunization Practices (ACIP) that modeled the potential impact of recommending high-dose, adjuvanted and recombinant vaccines to adults aged 65 and over on seasonal influenza burden in the United States.
Population structure, spatial diffusion, and climatic conditions mediate the spatiotemporal spread of seasonal influenza in temperate regions. However, much of our knowledge of these dynamics stems from a few well-studied countries, such as the …